WCPO: Asian American and Pacific Islander Heritage Month series
UC faculty and students share their personal stories with local journalists
Two faculty members and one student have been profiled by WCPO-TV as part of a series celebrating May as Asian American and Pacific Islander Heritage Month (AAPI). Since 1990, the U.S. government has designated May as AAPI month to celebrate the achievements and contributions of Asian Americans and Pacific Islanders in the United States.
WCPO-TV aired three segments featuring the stories of Jenn Dye, PhD, director of the Jones Center for Race, Gender and Social Justice at UC Law; Thomas Gamboa, PhD, assistant professor and assistant director of wind studies at CCM; and Aashka Raval, a fourth-year UC student and founder of the student group United Asian Advocates. Other WCPO segments feature additional residents from Greater Cincinnati in honor of AAPI month.
Watch the segments featuring Jenn Dye, PhD; Thomas Gamboa, PhD, and Aashka Raval.
Featured top image: Courtesy of Istock.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.